Jason P. Rhodes - Oct 4, 2021 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Signature
/s/ Jason Meyenburg, attorney-in-fact
Stock symbol
IRON
Transactions as of
Oct 4, 2021
Transactions value $
$0
Form type
4
Date filed
10/6/2021, 04:15 PM
Previous filing
Sep 29, 2021
Next filing
Apr 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Award $0 +17.2K $0.00 17.2K Oct 4, 2021 Common Stock 17.2K $3.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.
F2 This option was granted to the Reporting Person, a director of the Issuer and a member of Atlas Venture Life Science Advisors, LLC ("Atlas"). The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.